Medicine and Dentistry
Nicotine Withdrawal
100%
Smoking
98%
Abstinence
51%
Varenicline
33%
Bupropion
29%
Malignant Neoplasm
28%
Placebo
25%
Smoke
21%
Alcoholic Polyneuropathy
20%
Randomized Clinical Trial
20%
Biological Marker
15%
Carbon Monoxide
15%
Randomized Controlled Trial
14%
Electronic Cigarette
13%
Attentional Bias
13%
Nicotine Replacement Therapy
12%
Adverse Event
11%
Tobacco Use
8%
Event-Related Potential
8%
Tobacco Dependence
8%
Counseling
8%
Cue Reactivity
7%
Prevalence
7%
Cigarette Smoking
7%
Diseases
7%
Drug Therapy
7%
Breast Cancer
6%
Functional Magnetic Resonance Imaging
6%
Conduct Disorder
6%
Smoking Reduction
6%
Panic Disorder
6%
Facial Electromyography
6%
Blood Oxygenation
6%
Topiramate
6%
Biological Activity
6%
Health Care Cost
6%
Pooled Analysis
6%
Smoking Cessation Program
6%
Depressive Disorder
6%
Rimonabant
6%
Early Intervention
6%
Eye Tracking
6%
Cancer Diagnosis
6%
Odds Ratio
5%
Clinical Trial
5%
Insula
5%
Keyphrases
Smokers
64%
Smoking Cessation
58%
Cigarette
39%
Abstinence
25%
Bupropion
24%
Smoking Abstinence
22%
Smoking Cessation Intervention
20%
Varenicline
20%
Nicotine Replacement Therapy
17%
Nicotine
16%
Pharmacotherapy
15%
Quit Smoking
15%
Cue Reactivity
14%
Comprehensive Cancer Center
13%
Smoking Reduction
13%
Randomized Controlled Trial
13%
Attention Bias Modification Training
13%
Very Low Nicotine Content Cigarettes
12%
Smoking Behavior
10%
Emotional Images
10%
Cancer Patients
10%
Startle Response
10%
Nicotine Reduction
9%
Abstainers
9%
Abstinence Rate
9%
Nicotine Deprivation
9%
Gradual Reduction
9%
Smoking Cues
9%
Negative Affect
9%
Event-related Potentials
9%
Brain Response
8%
Nicotine Content
8%
Treatment Programs
8%
Tobacco Treatment
8%
Tobacco Cessation
7%
Survival Outcomes
7%
Bupropion Sustained Release
7%
Motivational Relevance
7%
Heavy Smokers
7%
Cessation Interventions
7%
Cognitive Bias Modification
7%
Personalized Treatment
7%
Substance Use Disorder
7%
New Targets
7%
Attentional Bias
7%
Prolonged Abstinence
7%
Point-prevalence Abstinence
7%
Cytochrome P450 2D6 (CYP2D6)
6%
DSM-IV
6%
Breast Cancer Patients
6%